v3.26.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2026
Jan. 31, 2026
Current assets:    
Cash and cash equivalents $ 90,310 $ 94,123
Restricted cash 2,788 2,805
Accounts receivable, net of allowance for credit losses of approximately $251 and $382 as of July 31, 2026 and January 31, 2026, respectively 67,400 154,811
Prepaid expenses and other current assets 53,442 34,876
Assets held for sale 0 81,279
Total current assets 213,940 367,894
Goodwill 287,650 287,650
Intangible assets, net 240,257 285,138
Other assets 24,680 22,436
Total assets 766,527 963,118
Current liabilities:    
Current maturities of long-term debt 6,404 6,404
Borrowings under accounts receivable facility 1,000 1,000
Accounts payable 8,517 15,170
Accrued compensation 21,417 37,280
Accrued expenses and other current liabilities 17,280 17,934
Deferred revenue 190,588 257,331
Liabilities associated with assets held for sale 0 41,822
Total current liabilities 245,206 376,941
Long-term debt 567,165 570,769
Deferred tax liabilities 30,887 33,849
Deferred revenue - non-current 991 1,117
Other long-term liabilities 15,562 10,669
Total long-term liabilities 614,605 616,404
Commitments and contingencies
Shareholders’ equity (deficit):    
Shareholders’ common stock - Class A common shares, $0.0001 par value per share: 18,750,000 shares authorized and 9,362,304 shares issued and 9,062,527 shares outstanding as of July 31, 2026, and 9,095,922 shares issued and 8,796,145 shares outstanding as of January 31, 2026 1 1
Additional paid-in capital 1,581,103 1,576,794
Accumulated (deficit) (1,668,692) (1,583,210)
Treasury stock, at cost - 299,777 shares as of July 31, 2026 and January 31, 2026 (10,891) (10,891)
Accumulated other comprehensive income (loss) 5,195 (12,921)
Total shareholders’ equity (deficit) (93,284) (30,227)
Total liabilities and shareholders’ equity (deficit) $ 766,527 $ 963,118